Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill creates financial penalties for companies that break FDA rules about handling human cells and tissues used in medical treatments. The FDA must hold workshops to teach people about these products and create a way for the public to submit comments. The agency also has to make educational materials for doctors about organ and tissue donations, publish information about a special FDA working group that advises on these products, and report to Congress with recommendations. For three years, the FDA must publish annual reports on its website about inquiries and inspections related to companies that make human cell and tissue products.

Your Vote